Your browser doesn't support javascript.
The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health Threats.
Harley, John B; Pyarajan, Saiju; Partan, Elizabeth S; Epstein, Lauren; Wertheim, Jason A; Diwan, Abhinav; Woods, Christopher W; Davey, Victoria; Blair, Sharlene; Clark, Dennis H; Kaufman, Kenneth M; Khan, Shagufta; Chepelev, Iouri; Devine, Alexander; Cameron, Perry; McCann, Monica F; Ammons, Mary Cloud B; Bolz, Devin D; Battles, Jane K; Curtis, Jeffrey L; Holodniy, Mark; Marconi, Vincent C; Searles, Charles D; Beenhouwer, David O; Brown, Sheldon T; Moorman, Jonathan P; Yao, Zhi Q; Rodriguez-Barradas, Maria C; Mohapatra, Shyam; Molina De Rodriguez, Osmara Y; Padiernos, Emerson B; McIndoo, Eric R; Price, Emily; Burgoyne, Hailey M; Robey, Ian; Schwenke, Dawn C; Shive, Carey L; Przygodzki, Ronald M; Ramoni, Rachel B; Krull, Holly K; Bonomo, Robert A.
  • Harley JB; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Pyarajan S; Center for Data and Computational Sciences, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
  • Partan ES; Center for Data and Computational Sciences, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
  • Epstein L; Infectious Diseases, US Department of Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Wertheim JA; Research & Development, Southern Arizona Veterans Affairs Healthcare System, US Department of Veterans Affairs, Tucson, Arizona, USA.
  • Diwan A; Cardiology, Veterans Affairs Saint Louis Healthcare System, US Department of Veterans Affairs, Saint Louis, Missouri, USA.
  • Woods CW; Medicine, US Department of Veterans Affairs Medical Center, Durham, North Carolina, USA.
  • Davey V; Office of Research and Development, US Department of Veterans Affairs, Washington, District of Columbia, USA.
  • Blair S; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Clark DH; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Kaufman KM; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Khan S; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Chepelev I; Research Services, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
  • Devine A; Prometheus Federal Services, Titan Alpha, Washington, District of Columbia, USA.
  • Cameron P; Customer Value Partners, Titan Alpha, Washington, District of Columbia, USA.
  • McCann MF; Office of Research and Development, Chesapeake Medical Communications, Contractor for the US Department of Veterans Affairs, Washington, District of Columbia, USA.
  • Ammons MCB; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
  • Bolz DD; Idaho Veterans Research and Education Foundation, Boise, Idaho, USA.
  • Battles JK; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
  • Curtis JL; Office of Research and Development, US Department of Veterans Affairs, Washington, District of Columbia, USA.
  • Holodniy M; Medicine Service, Veteran Affairs Ann Arbor Healthcare System, US Department of Veterans Affairs, Ann Arbor, Michigan, USA.
  • Marconi VC; Public Health Surveillance, Veterans Affairs Palo Alto Healthcare System, US Department of Veterans Affairs, Palo Alto, California, USA.
  • Searles CD; Infectious Diseases, US Department of Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Beenhouwer DO; Division of Infectious Diseases, Emory School of Medicine and Rollins School of Public Health, Atlanta, Georgia, USA.
  • Brown ST; Infectious Diseases, US Department of Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Moorman JP; Medicine, Veterans Affairs Greater Los Angeles Healthcare System, US Department of Veterans Affairs, Los Angeles, California, USA.
  • Yao ZQ; Infectious Diseases, James J. Peters Veterans Affairs Medical Center, US Department of Veterans Affairs, Bronx, New York, USA.
  • Rodriguez-Barradas MC; Infectious Diseases, James H. Quillen Veterans Affairs Medical Center, US Department of Veterans Affairs, Mountain Home, Tennessee, USA.
  • Mohapatra S; Center of Excellence in Inflammation, Infectious Diseases, and Immunity, East Tennessee State University, Johnson City, Tennessee, USA.
  • Molina De Rodriguez OY; Infectious Diseases, James H. Quillen Veterans Affairs Medical Center, US Department of Veterans Affairs, Mountain Home, Tennessee, USA.
  • Padiernos EB; Center of Excellence in Inflammation, Infectious Diseases, and Immunity, East Tennessee State University, Johnson City, Tennessee, USA.
  • McIndoo ER; Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center, US Department of Veterans Affairs, Houston, Texas, USA.
  • Price E; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Burgoyne HM; Medicine, James A. Haley Veterans Hospital, US Department of Veterans Affairs, Tampa, Florida, USA.
  • Robey I; Research & Development, Southern Arizona Veterans Affairs Healthcare System, US Department of Veterans Affairs, Tucson, Arizona, USA.
  • Schwenke DC; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
  • Shive CL; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
  • Przygodzki RM; Idaho Veterans Research and Education Foundation, Boise, Idaho, USA.
  • Ramoni RB; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
  • Krull HK; Idaho Veterans Research and Education Foundation, Boise, Idaho, USA.
  • Bonomo RA; Research, US Department of Veterans Affairs Medical Center, Boise, Idaho, USA.
Open Forum Infect Dis ; 9(12): ofac641, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2190082
ABSTRACT

Background:

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has demonstrated the need to share data and biospecimens broadly to optimize clinical outcomes for US military Veterans.

Methods:

In response, the Veterans Health Administration established VA SHIELD (Science and Health Initiative to Combat Infectious and Emerging Life-threatening Diseases), a comprehensive biorepository of specimens and clinical data from affected Veterans to advance research and public health surveillance and to improve diagnostic and therapeutic capabilities.

Results:

VA SHIELD now comprises 12 sites collecting de-identified biospecimens from US Veterans affected by SARS-CoV-2. In addition, 2 biorepository sites, a data processing center, and a coordinating center have been established under the direction of the Veterans Affairs Office of Research and Development. Phase 1 of VA SHIELD comprises 34 157 samples. Of these, 83.8% had positive tests for SARS-CoV-2, with the remainder serving as contemporaneous controls. The samples include nasopharyngeal swabs (57.9%), plasma (27.9%), and sera (12.5%). The associated clinical and demographic information available permits the evaluation of biological data in the context of patient demographics, clinical experience and management, vaccinations, and comorbidities.

Conclusions:

VA SHIELD is representative of US national diversity with a significant potential to impact national healthcare. VA SHIELD will support future projects designed to better understand SARS-CoV-2 and other emergent healthcare crises. To the extent possible, VA SHIELD will facilitate the discovery of diagnostics and therapeutics intended to diminish COVID-19 morbidity and mortality and to reduce the impact of new emerging threats to the health of US Veterans and populations worldwide.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Vaccines Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Vaccines Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid